Tim Fitzgerald, joined Bridgehead in July 2001 from Aventis, after nearly 20 years in the pharmaceutical industry.
He has considerable sales, marketing, commercial and general management experience, gained in the UK, Europe and the Middle East.
Tim specializes in pricing, reimbursement and market access strategy but remains actively involved in opportunity evaluation and commercial due diligence, providing support and counsel to clients during mergers, acquisitions, initial public offerings and pre-investment decision making.
In the market access field, Tim combines a deep understanding of pricing and reimbursement systems, health technology assessment and health economics, with solid hands on experience, gained negotiating listing and access with both private and public payers.
Having originally trained as a Biologist, Tim has considerable commercial experience in a variety of therapeutic areas including cardiovascular, dermatology, diabetes, anti-infectives and oncology.
Tim speaks German and Portuguese and is a member of ISPOR and the IOD.
